These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 24780866)
21. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine. Zarepour L; Fatahi Z; Sarihi A; Haghparast A Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540 [TBL] [Abstract][Full Text] [Related]
22. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats. Tan SE Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625 [TBL] [Abstract][Full Text] [Related]
23. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse. Zocchi A; Girlanda E; Varnier G; Sartori I; Zanetti L; Wildish GA; Lennon M; Mugnaini M; Heidbreder CA Synapse; 2003 Dec; 50(4):293-302. PubMed ID: 14556234 [TBL] [Abstract][Full Text] [Related]
24. Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area. Liu C; Fang X; Wu Q; Jin G; Zhen X Neuropharmacology; 2015 Aug; 95():299-308. PubMed ID: 25882828 [TBL] [Abstract][Full Text] [Related]
25. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Bassareo V; De Luca MA; Di Chiara G Psychopharmacology (Berl); 2007 Apr; 191(3):689-703. PubMed ID: 17072592 [TBL] [Abstract][Full Text] [Related]
26. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Hu XT; Koeltzow TE; Cooper DC; Robertson GS; White FJ; Vezina P Synapse; 2002 Sep; 45(3):159-70. PubMed ID: 12112395 [TBL] [Abstract][Full Text] [Related]
27. Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference. Lasheras MC; Laorden ML; Milanés MV; Núñez C Neuropharmacology; 2015 Aug; 95():168-80. PubMed ID: 25556110 [TBL] [Abstract][Full Text] [Related]
28. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area. Esmaeili MH; Kermani M; Parvishan A; Haghparast A Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507 [TBL] [Abstract][Full Text] [Related]
29. A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats. Edvardsson CE; Vestlund J; Jerlhag E Eur J Pharmacol; 2021 May; 899():174039. PubMed ID: 33737011 [TBL] [Abstract][Full Text] [Related]
30. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core. Kobrin KL; Arena DT; Heinrichs SC; Nguyen OH; Kaplan GB Behav Brain Res; 2017 Mar; 322(Pt A):18-28. PubMed ID: 28089852 [TBL] [Abstract][Full Text] [Related]
31. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference. Zarrindast MR; Azami BN; Rostami P; Rezayof A Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879 [TBL] [Abstract][Full Text] [Related]
32. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study. Kao JH; Huang EY; Tao PL Drug Alcohol Depend; 2011 Nov; 118(2-3):366-74. PubMed ID: 21601998 [TBL] [Abstract][Full Text] [Related]
33. Expression of activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) in the nucleus accumbens is critical for the acquisition, expression and reinstatement of morphine-induced conditioned place preference. Lv XF; Xu Y; Han JS; Cui CL Behav Brain Res; 2011 Sep; 223(1):182-91. PubMed ID: 21549764 [TBL] [Abstract][Full Text] [Related]
34. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108 [TBL] [Abstract][Full Text] [Related]
35. Amphetamine and morphine produce a conditioned taste and place preference in the house musk shrew (Suncus murinus). Parker LA; Corrick ML; Limebeer CL; Kwiatkowska M J Exp Psychol Anim Behav Process; 2002 Jan; 28(1):75-82. PubMed ID: 11868236 [TBL] [Abstract][Full Text] [Related]
36. Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats. Sadeghzadeh F; Babapour V; Haghparast A Behav Brain Res; 2015; 287():172-81. PubMed ID: 25835321 [TBL] [Abstract][Full Text] [Related]
37. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Olmstead MC; Franklin KB Behav Neurosci; 1997 Dec; 111(6):1324-34. PubMed ID: 9438801 [TBL] [Abstract][Full Text] [Related]
38. Intrahippocampal administration of D2 but not D1 dopamine receptor antagonist suppresses the expression of conditioned place preference induced by morphine in the ventral tegmental area. Haghparast A; Esmaeili MH; Taslimi Z; Kermani M; Yazdi-Ravandi S; Alizadeh AM Neurosci Lett; 2013 Apr; 541():138-43. PubMed ID: 23499959 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. David V; Durkin TP; Cazala P Psychopharmacology (Berl); 2002 Mar; 160(3):307-17. PubMed ID: 11889500 [TBL] [Abstract][Full Text] [Related]
40. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal. Sun L; Hu L; Li Y; Cui C Brain Struct Funct; 2014 Sep; 219(5):1755-71. PubMed ID: 23775491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]